SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021188
Filing Date
2023-05-11
Accepted
2023-05-11 16:02:37
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20230331.htm   iXBRL 10-Q 1714267
2 EX-10.1 vor-ex10_1.htm EX-10 26848
3 EX-31.1 vor-ex31_1.htm EX-31 20802
4 EX-31.2 vor-ex31_2.htm EX-31 20806
5 EX-32.1 vor-ex32_1.htm EX-32 24081
  Complete submission text file 0000950170-23-021188.txt   6641264

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20230331_def.xml EX-101.DEF 125641
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20230331.xsd EX-101.SCH 41770
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20230331_lab.xml EX-101.LAB 348398
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20230331_cal.xml EX-101.CAL 42167
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20230331_pre.xml EX-101.PRE 237141
53 EXTRACTED XBRL INSTANCE DOCUMENT vor-20230331_htm.xml XML 1349187
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 23910821
SIC: 2836 Biological Products, (No Diagnostic Substances)